单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China内科学系血液内科华中科技大学同济医学院附属同济医院[2]Shanxi Med Univ, Hosp 3, Tongji Shanxi Hosp, Dept Hematol,Shanxi Bethune Hosp,Shanxi Acad Med, Taiyuan, Peoples R China[3]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Clin Lab, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[4]Shanxi Acad Med Sci, Shanxi Bethune Hosp, Sino German Joint Oncol Res Lab, Taiyuan, Peoples R China
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China
推荐引用方式(GB/T 7714)：
Yang Xingcheng,Zhang Xiaoying,Peng Juan,et al.Soluble PD-L1 Predicts Poor Outcome and Disease Progression in Patients with De Novo Myelodysplastic Syndromes[J].BLOOD.2023,142:doi:10.1182/blood-2023-190744.
APA：
Yang, Xingcheng,Zhang, Xiaoying,Peng, Juan,Huang, Lifang,He, Shaolong...&Wei, Jia.(2023).Soluble PD-L1 Predicts Poor Outcome and Disease Progression in Patients with De Novo Myelodysplastic Syndromes.BLOOD,142,
MLA：
Yang, Xingcheng,et al."Soluble PD-L1 Predicts Poor Outcome and Disease Progression in Patients with De Novo Myelodysplastic Syndromes".BLOOD 142.(2023)
医学